Therapeutic effects of KCC2 chloride transporter activation on detrusor overactivity in mice with spinal cord injury

• Published in: American journal of physiology. Renal physiology 2023-04, Vol.324 (4), p.F353-F361
• Main Authors: Watanabe, Kyohei, Ishibashi, Masaru, Suzuki, Takahisa, Otsuka, Atsushi, Yoshimura, Naoki, Miyake, Hideaki, Fukuda, Atsuo
• Format: Article
• Language: English
• Subjects: Acetyltransferase; Animals; c-Fos protein; Cell membranes; Chlorides - metabolism; Choline O-acetyltransferase; Choline O-Acetyltransferase - metabolism; Choline O-Acetyltransferase - pharmacology; Choline O-Acetyltransferase - therapeutic use; Female; Firing pattern; Firing rate; Immunohistochemistry; Mice; Mice, Inbred C57BL; Neurons; Parasympathetic nervous system; Potassium-chloride cotransporter; Sacrum; Spinal Cord - metabolism; Spinal cord injuries; Spinal Cord Injuries - complications; Symporters
• ISSN: 1931-857X; 1522-1466
• DOI: 10.1152/ajprenal.00271.2022

This study aimed to clarify whether downregulation of K -Cl cotransporter 2 (KCC2) in the sacral parasympathetic nucleus (SPN) of the lumbosacral spinal cord, from which the efferent pathway innervating the bladder originates, causes cellular hyperexcitability and triggers detrusor overactivity (DO) in spinal cord injury (SCI). SCI was produced by Th8-9 spinal cord transection in female C57BL/6 mice. At 4 wk after SCI, CLP290, a KCC2 activator, was administered, and cystometry was performed. Thereafter, neuronal activity with c-fos staining and KCC2 expression in cholinergic preganglionic parasympathetic neurons in the SPN was examined using immunohistochemistry. Firing properties of neurons in the SPN region were evaluated by extracellular recordings in the spinal cord slice preparations. DO evident as nonvoiding contractions was significantly reduced by CLP290 treatment in SCI mice. The number of c-fos-positive cells and coexpression of c-fos in choline acetyltransferase-positive cells were decreased in the SPN region of the SCI CLP290-treated group versus the SCI vehicle-treated group. KCC2 immunoreactivity was present on the cell membrane of SPN neurons and normalized fluorescence intensity of KCC2 in choline acetyltransferase-positive SPN neurons was decreased in the SCI vehicle-treated group versus the spinal intact vehicle-treated group but recovered in the SCI CLP290-treated group. Extracellular recordings showed that CLP290 suppressed the high-frequency firing activity of SPN neurons in SCI mice. These results indicated that SCI-induced DO is associated with downregulation of KCC2 in preganglionic parasympathetic neurons and that activation of KCC2 transporters can reduce DO, increase KCC2 expression in preganglionic parasympathetic neurons, and decrease neuronal firing of SPN neurons in SCI mice. This study is the first report to suggest that activation of the Cl transporter K -Cl cotransporter 2 may be a therapeutic modality for the treatment of spinal cord injury-induced detrusor overactivity by targeting bladder efferent pathways.